Your browser doesn't support javascript.
loading
Novel monkey mAbs induced by a therapeutic vaccine targeting the hepatitis B surface antigen effectively suppress hepatitis B virus in mice.
Chen, Yuanzhi; Xiang, Xinchu; Qi, Ruoyao; Wang, Yiwen; Huang, Yang; You, Min; Xian, Yangfei; Wu, Yangtao; Fu, Rao; Kang, Ciming; Tang, Jixian; Yu, Hai; Zhang, Tianying; Yuan, Quan; Luo, Wenxin; Xia, Ningshao.
Afiliación
  • Chen Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Xiang X; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Qi R; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Wang Y; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Huang Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • You M; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Xian Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Wu Y; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Fu R; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Kang C; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Tang J; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Yu H; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Zhang T; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Yuan Q; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Luo W; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
  • Xia N; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health and School of Life Science, Xiamen University, Xiamen 361102, China.
Antib Ther ; 4(4): 197-207, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34646979

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Antib Ther Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Antib Ther Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos